SLGC News and Press, SomaLogic Inc. From 12/12/23

2023-12-12 17:17:05 ET SomaLogic Inc. (SLGC) Q3 2023 Earnings Call Transcript SomaLogic rebounds after selloff on news of merger with Standard BioTools Standard BioTools and SomaLogic to combine in an all stock merger Seeking Alpha’s Quant Rating on SomaLo...

NEW YORK, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating the proposed all-stock merger between Standard BioTools Inc. (“Standard BioTools”) (NASDAQ: LAB) and SomaLogic, Inc. (“S...

SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – and SomaLogic, Inc. (Nasdaq: SLGC), a leader in data-driven proteomics te...

2023-11-10 13:34:05 ET SomaLogic Inc. (SLGC) Q3 2023 Results Conference Call November 8, 2023 4:30 PM ET Company Participants Noah Corin - IR, Gilmartin Group Adam Taich - Interim CEO Eliot Lurier - Interim Chief Financial Officer Conference Call Participan...

2023-11-09 10:00:37 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...

2023-11-08 16:21:57 ET More on SomaLogic SomaLogic rebounds after selloff on news of merger with Standard BioTools Standard BioTools and SomaLogic to combine in an all stock merger Seeking Alpha’s Quant Rating on SomaLogic Historical earnings data for ...

Revenue of $22.0 million, reflecting 14% year-over-year growth when excluding royalty revenue from NEB in the corresponding prior-year period Cash and investments of over $450 million Raising full year 2023 revenue guidance to $82 million to $85 million Management to host conference c...

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

SomaLogic Inc. (SLGC) is expected to report $-0.17 for Q3 2023

BOULDER, Colo., Nov. 01, 2023 (GLOBE NEWSWIRE) -- SomaLogic Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced the launch of its high-plex proteomics platform, which provides 11,000 total protein measurements. The SomaScan 11K Platform is the largest proteomics of...